112 related articles for article (PubMed ID: 1514604)
1. Epinephrine's ketogenic effect in humans is mediated principally by lipolysis.
Avogaro A; Cryer PE; Bier DM
Am J Physiol; 1992 Aug; 263(2 Pt 1):E250-60. PubMed ID: 1514604
[TBL] [Abstract][Full Text] [Related]
2. Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man.
Weiss M; Keller U; Stauffacher W
Diabetes; 1984 Aug; 33(8):738-44. PubMed ID: 6146545
[TBL] [Abstract][Full Text] [Related]
3. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.
Avogaro A; Valerio A; Gnudi L; Maran A; Miola M; Duner E; Marescotti C; Iori E; Tiengo A; Nosadini R
Diabetologia; 1992 Feb; 35(2):129-38. PubMed ID: 1547916
[TBL] [Abstract][Full Text] [Related]
4. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
Staten MA; Matthews DE; Cryer PE; Bier DM
Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
[TBL] [Abstract][Full Text] [Related]
5. Effects of free fatty acids, insulin, glucagon and adrenaline on ketone body production in humans.
Miles JM; Haymond MW; Gerich JE
Ciba Found Symp; 1982; 87():192-213. PubMed ID: 7042239
[TBL] [Abstract][Full Text] [Related]
6. Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects.
Avogaro A; Gnudi L; Valerio A; Maran A; Miola M; Opportuno A; Tiengo A; Bier DM
J Clin Endocrinol Metab; 1993 Apr; 76(4):845-50. PubMed ID: 8473394
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of physiological versus pathophysiological plasma concentrations of epinephrine and norepinephrine on ketone body metabolism and hepatic portal blood flow in man.
Krentz AJ; Freedman D; Greene R; McKinley M; Boyle PJ; Schade DS
Metabolism; 1996 Oct; 45(10):1214-20. PubMed ID: 8843175
[TBL] [Abstract][Full Text] [Related]
8. Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man.
Miles JM; Haymond MW; Nissen SL; Gerich JE
J Clin Invest; 1983 Jun; 71(6):1554-61. PubMed ID: 6134753
[TBL] [Abstract][Full Text] [Related]
9. Effect of physiological elevation of plasma growth hormone levels on ketone body kinetics and lipolysis in normal and acutely insulin-deficient man.
Keller U; Schnell H; Girard J; Stauffacher W
Diabetologia; 1984 Feb; 26(2):103-8. PubMed ID: 6143702
[TBL] [Abstract][Full Text] [Related]
10. Effect of ketone bodies on glucose production and utilization in the miniature pig.
Müller MJ; Paschen U; Seitz HJ
J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
[TBL] [Abstract][Full Text] [Related]
11. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
[TBL] [Abstract][Full Text] [Related]
12. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise.
Wahren J; Sato Y; Ostman J; Hagenfeldt L; Felig P
J Clin Invest; 1984 May; 73(5):1367-76. PubMed ID: 6715541
[TBL] [Abstract][Full Text] [Related]
13. Effect of epinephrine on the relationship between nonesterified fatty acid availability and ketone body production in postabsorptive man: evidence for a hepatic antiketogenic effect of epinephrine.
Beylot M; Beaufrere B; Riou JP; Khalfallah Y; Moneger A; Odeon M; Cohen R; Mornex R
J Clin Endocrinol Metab; 1987 Nov; 65(5):914-21. PubMed ID: 3667886
[TBL] [Abstract][Full Text] [Related]
14. Effect of stress hormones on splanchnic substrate and insulin disposal after glucose ingestion in healthy humans.
Waldhäusl WK; Gasic S; Bratusch-Marrain P; Komjati M; Korn A
Diabetes; 1987 Feb; 36(2):127-35. PubMed ID: 3542641
[TBL] [Abstract][Full Text] [Related]
15. A dual-isotope technique for determination of in vivo ketone body kinetics.
Miles JM; Schwenk WF; McClean KL; Haymond MW
Am J Physiol; 1986 Aug; 251(2 Pt 1):E185-91. PubMed ID: 3526920
[TBL] [Abstract][Full Text] [Related]
16. Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans.
Divertie GD; Jensen MD; Cryer PE; Miles JM
Am J Physiol; 1997 Jun; 272(6 Pt 1):E1130-5. PubMed ID: 9227461
[TBL] [Abstract][Full Text] [Related]
17. Contribution of alpha- and beta-receptors to ketogenic and lipolytic effects of norepinephrine in humans.
Keller U; Weiss M; Stauffacher W
Diabetes; 1989 Apr; 38(4):454-9. PubMed ID: 2538376
[TBL] [Abstract][Full Text] [Related]
18. Validation of a tracer technique to determine nonsteady-state ketone body turnover rates in man.
Keller U; Sonnenberg GE; Stauffacher W
Am J Physiol; 1981 Mar; 240(3):E253-62. PubMed ID: 7011051
[TBL] [Abstract][Full Text] [Related]
19. Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses.
Owen OE; Reichard GA; Markus H; Boden G; Mozzoli MA; Shuman CR
J Clin Invest; 1973 Oct; 52(10):2606-16. PubMed ID: 4729054
[TBL] [Abstract][Full Text] [Related]
20. Effect of exercise on lipolytic sensitivity in endurance-trained athletes.
Klein S; Coyle EF; Wolfe RR
J Appl Physiol (1985); 1995 Jun; 78(6):2201-6. PubMed ID: 7665418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
